Literature DB >> 1314715

Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells.

Y P Au1, K F Montgomery, A W Clowes.   

Abstract

Heparin is a potent inhibitor of arterial smooth muscle cell (SMC) migration and proliferation in vivo and in vitro. We propose that heparin affects these SMC functions by interfering with either the expression or the activity of secreted proteases required for cell movement. We have reported that heparin selectively inhibits the expression of tissue-type plasminogen activator in SMCs during mitogenesis. In this study we show that the gene expression of another kind of protease, interstitial collagenase, is induced by fetal bovine serum and is also suppressed by heparin. The inhibitory effect on the induced collagenase mRNA is specific to heparin-like molecules and does not depend on the anticoagulant activity of heparin. The induction of the collagenase gene depends on the protein kinase C pathway, since it can be induced by phorbol esters such as phorbol 12-myristate 13-acetate and blocked by inhibitors such as H-7 and staurosporine. In transient transfection assays with chloramphenicol acetyltransferase constructs containing the phorbol ester-responsive element introduced into baboon SMCs, heparin inhibits transcription induced by serum or phorbol 12-myristate 13-acetate. These results support the conclusion that, in primate SMCs, interstitial collagenase gene transcription mediated by the phorbol ester-responsive element is blocked by heparin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314715     DOI: 10.1161/01.res.70.5.1062

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

1.  Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy.

Authors:  Matteo Ceccarelli; Daniele Bani; Lorenzo Cinci; Silvia Nistri; Caterina Uliva; Elena Ragazzo; Alfredo Vannacci; Marco Manoni; Anna Maria Gori; Rosanna Abbate; Gian Franco Gensini; Emanuela Masini
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

2.  Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis.

Authors:  M K Patel; J S Refson; M Schachter; A D Hughes
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Regulation of vascular smooth muscle proliferation by heparin: inhibition of cyclin-dependent kinase 2 activity by p27(kip1).

Authors:  Stephen Fasciano; Rekha C Patel; Indhira Handy; Chandrashekhar V Patel
Journal:  J Biol Chem       Date:  2005-02-24       Impact factor: 5.157

4.  Synergies of heparin and second messengers pathways involved in tissue-specific gene expression in hepatocytes.

Authors:  I Zvibel; P Moshe; H Zamir; B Shlomo
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

5.  Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production.

Authors:  G P Amorino; R L Hoover
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

6.  Intrauterine proteolytic enzymes therapy hastens expulsion of fetal membranes in dystocia affected buffaloes.

Authors:  N Gulia; M Honparkhe; A Bisla; A K Singh; P Singh
Journal:  Iran J Vet Res       Date:  2022       Impact factor: 1.226

7.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Smooth muscle cell expression of extracellular matrix genes after arterial injury.

Authors:  S T Nikkari; H T Järveläinen; T N Wight; M Ferguson; A W Clowes
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

9.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

Authors:  R L Meek; S Urieli-Shoval; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development.

Authors:  Efstathios Vassiliadis; Natasha Barascuk; Morten A Karsdal
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.